Software - Application
Compare Stocks
5 / 10Stock Comparison
RDZN vs HIPO vs METC vs KINS vs ROOT
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Specialty
Coal
Insurance - Property & Casualty
Insurance - Property & Casualty
RDZN vs HIPO vs METC vs KINS vs ROOT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Insurance - Specialty | Coal | Insurance - Property & Casualty | Insurance - Property & Casualty |
| Market Cap | $149M | $714M | $735M | $234M | $798M |
| Revenue (TTM) | $48M | $480M | $537M | $199M | $1.56B |
| Net Income (TTM) | $-9.15T | $113M | $-51M | $41M | $56M |
| Gross Margin | 63.7% | 40.5% | 2.5% | 57.7% | 17.9% |
| Operating Margin | -16.5% | 24.2% | -10.4% | 25.6% | 4.1% |
| Forward P/E | — | 114.3x | — | 7.0x | 29.0x |
| Total Debt | $24M | $52M | $18M | $4M | $201M |
| Cash & Equiv. | $5M | $250M | $440M | $12M | $690M |
RDZN vs HIPO vs METC vs KINS vs ROOT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 22 | May 26 | Return |
|---|---|---|---|
| Roadzen, Inc. (RDZN) | 100 | 18.9 | -81.1% |
| Hippo Holdings Inc. (HIPO) | 100 | 52.3 | -47.7% |
| Ramaco Resources, I… (METC) | 100 | 125.4 | +25.4% |
| Kingstone Companies… (KINS) | 100 | 298.2 | +198.2% |
| Root, Inc. (ROOT) | 100 | 157.3 | +57.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RDZN vs HIPO vs METC vs KINS vs ROOT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RDZN is the #2 pick in this set and the best alternative if momentum is your priority.
- +169.5% vs ROOT's -59.3%
HIPO ranks third and is worth considering specifically for quality.
- 23.4% margin vs RDZN's -63.7%
Among these 5 stocks, METC doesn't own a clear edge in any measured category.
KINS carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.28, yield 0.6%
- 101.9% 10Y total return vs METC's 21.4%
- Lower volatility, beta 0.28, Low D/E 3.6%, current ratio 1.22x
- Beta 0.28, yield 0.6%, current ratio 1.22x
ROOT is the clearest fit if your priority is growth exposure.
- Rev growth 29.0%, EPS growth 22.4%, 3Y rev CAGR 69.6%
- 29.0% revenue growth vs METC's -19.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 29.0% revenue growth vs METC's -19.5% | |
| Value | Lower P/E (7.0x vs 29.0x) | |
| Quality / Margins | 23.4% margin vs RDZN's -63.7% | |
| Stability / Safety | Beta 0.28 vs RDZN's 2.44 | |
| Dividends | 0.6% yield, vs METC's 0.6%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +169.5% vs ROOT's -59.3% | |
| Efficiency (ROA) | 9.8% ROA vs RDZN's -20.4% |
RDZN vs HIPO vs METC vs KINS vs ROOT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
RDZN vs HIPO vs METC vs KINS vs ROOT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KINS leads in 5 of 6 categories
RDZN leads 0 • HIPO leads 0 • METC leads 0 • ROOT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
KINS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ROOT is the larger business by revenue, generating $1.6B annually — 32.6x RDZN's $48M. HIPO is the more profitable business, keeping 23.4% of every revenue dollar as net income compared to RDZN's -63.7%. On growth, RDZN holds the edge at +999999.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $48M | $480M | $537M | $199M | $1.6B |
| EBITDAEarnings before interest/tax | -$2.05T | $116M | $13M | $54M | $73M |
| Net IncomeAfter-tax profit | -$9.15T | $113M | -$51M | $41M | $56M |
| Free Cash FlowCash after capex | -$825.5B | $50M | -$67M | $73M | $181M |
| Gross MarginGross profit ÷ Revenue | +63.7% | +40.5% | +2.5% | +57.7% | +17.9% |
| Operating MarginEBIT ÷ Revenue | -16.5% | +24.2% | -10.4% | +25.6% | +4.1% |
| Net MarginNet income ÷ Revenue | -63.7% | +23.4% | -9.6% | +20.5% | +3.6% |
| FCF MarginFCF ÷ Revenue | -5.8% | +10.4% | -12.5% | +36.7% | +11.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +999999.0% | +10.2% | -25.1% | -3.2% | +12.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.3% | +114.1% | -5.1% | +157.5% | +95.3% |
Valuation Metrics
KINS leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 5.6x trailing earnings, KINS trades at a 78% valuation discount to ROOT's 25.4x P/E. On an enterprise value basis, KINS's 4.2x EV/EBITDA is more attractive than METC's 25.6x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $149M | $714M | $735M | $234M | $798M |
| Enterprise ValueMkt cap + debt − cash | $168M | $517M | $312M | $226M | $309M |
| Trailing P/EPrice ÷ TTM EPS | -1.80x | 12.36x | -14.34x | 5.61x | 25.41x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 114.33x | — | 7.03x | 29.04x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.06x | — |
| EV / EBITDAEnterprise value multiple | — | 8.16x | 25.60x | 4.22x | 5.88x |
| Price / SalesMarket cap ÷ Revenue | 3.36x | 1.52x | 1.37x | 1.17x | 0.53x |
| Price / BookPrice ÷ Book value/share | — | 1.64x | 1.52x | 1.86x | 2.47x |
| Price / FCFMarket cap ÷ FCF | — | 78.49x | — | 3.20x | 4.15x |
Profitability & Efficiency
KINS leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
KINS delivers a 40.0% return on equity — every $100 of shareholder capital generates $40 in annual profit, vs $-11 for METC. KINS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to ROOT's 0.51x. On the Piotroski fundamental quality scale (0–9), KINS scores 7/9 vs RDZN's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +27.4% | -10.6% | +40.0% | +15.4% |
| ROA (TTM)Return on assets | -20.4% | +6.0% | -4.5% | +9.8% | +3.7% |
| ROICReturn on invested capital | — | +22.8% | -17.0% | +46.6% | — |
| ROCEReturn on capital employed | — | +6.9% | -7.1% | +20.3% | +3.8% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 4 | 7 | 6 |
| Debt / EquityFinancial leverage | — | 0.12x | 0.04x | 0.04x | 0.51x |
| Net DebtTotal debt minus cash | $19M | -$198M | -$423M | -$8M | -$489M |
| Cash & Equiv.Liquid assets | $5M | $250M | $440M | $12M | $690M |
| Total DebtShort + long-term debt | $24M | $52M | $18M | $4M | $201M |
| Interest CoverageEBIT ÷ Interest expense | -18.72x | — | -7.17x | 115.65x | 1.86x |
Total Returns (Dividends Reinvested)
KINS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in METC five years ago would be worth $40,611 today (with dividends reinvested), compared to $1,105 for HIPO. Over the past 12 months, RDZN leads with a +169.5% total return vs ROOT's -59.3%. The 3-year compound annual growth rate (CAGR) favors KINS at 127.2% vs RDZN's -43.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -21.1% | -8.5% | -21.1% | -0.3% | -19.7% |
| 1-Year ReturnPast 12 months | +169.5% | +12.2% | +52.5% | -10.1% | -59.3% |
| 3-Year ReturnCumulative with dividends | -82.2% | +48.3% | +57.4% | +1073.4% | +927.3% |
| 5-Year ReturnCumulative with dividends | -81.1% | -88.9% | +306.1% | +99.4% | -69.6% |
| 10-Year ReturnCumulative with dividends | -81.1% | -90.5% | +21.4% | +101.9% | -88.3% |
| CAGR (3Y)Annualised 3-year return | -43.7% | +14.0% | +16.3% | +127.2% | +117.4% |
Risk & Volatility
Evenly matched — RDZN and KINS each lead in 1 of 2 comparable metrics.
Risk & Volatility
KINS is the less volatile stock with a 0.28 beta — it tends to amplify market swings less than RDZN's 2.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RDZN currently trades 73.0% from its 52-week high vs METC's 25.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.44x | 1.40x | 1.07x | 0.28x | 2.30x |
| 52-Week HighHighest price in past year | $2.56 | $38.98 | $57.80 | $22.40 | $162.99 |
| 52-Week LowLowest price in past year | $0.68 | $19.92 | $8.21 | $13.08 | $40.91 |
| % of 52W HighCurrent price vs 52-week peak | +73.0% | +70.4% | +25.6% | +72.1% | +34.9% |
| RSI (14)Momentum oscillator 0–100 | 61.2 | 48.9 | 58.3 | 50.5 | 56.6 |
| Avg Volume (50D)Average daily shares traded | 346K | 110K | 1.8M | 113K | 330K |
Analyst Outlook
KINS leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: RDZN as "Buy", HIPO as "Buy", METC as "Buy", KINS as "Buy", ROOT as "Hold". Consensus price targets imply 41.0% upside for METC (target: $21) vs 3.4% for HIPO (target: $28). For income investors, KINS offers the higher dividend yield at 0.62% vs METC's 0.59%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $28.38 | $20.83 | — | $75.00 |
| # AnalystsCovering analysts | 1 | 6 | 9 | 4 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.6% | +0.6% | — |
| Dividend StreakConsecutive years of raises | — | — | 0 | 0 | — |
| Dividend / ShareAnnual DPS | — | — | $0.09 | $0.10 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.0% | 0.0% | 0.0% | 0.0% |
KINS leads in 5 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.
RDZN vs HIPO vs METC vs KINS vs ROOT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RDZN or HIPO or METC or KINS or ROOT a better buy right now?
For growth investors, Root, Inc.
(ROOT) is the stronger pick with 29. 0% revenue growth year-over-year, versus -19. 5% for Ramaco Resources, Inc. (METC). Kingstone Companies, Inc. (KINS) offers the better valuation at 5. 6x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate Roadzen, Inc. (RDZN) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RDZN or HIPO or METC or KINS or ROOT?
On trailing P/E, Kingstone Companies, Inc.
(KINS) is the cheapest at 5. 6x versus Root, Inc. at 25. 4x. On forward P/E, Kingstone Companies, Inc. is actually cheaper at 7. 0x.
03Which is the better long-term investment — RDZN or HIPO or METC or KINS or ROOT?
Over the past 5 years, Ramaco Resources, Inc.
(METC) delivered a total return of +306. 1%, compared to -88. 9% for Hippo Holdings Inc. (HIPO). Over 10 years, the gap is even starker: KINS returned +101. 9% versus HIPO's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RDZN or HIPO or METC or KINS or ROOT?
By beta (market sensitivity over 5 years), Kingstone Companies, Inc.
(KINS) is the lower-risk stock at 0. 28β versus Roadzen, Inc. 's 2. 44β — meaning RDZN is approximately 787% more volatile than KINS relative to the S&P 500. On balance sheet safety, Kingstone Companies, Inc. (KINS) carries a lower debt/equity ratio of 4% versus 51% for Root, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RDZN or HIPO or METC or KINS or ROOT?
By revenue growth (latest reported year), Root, Inc.
(ROOT) is pulling ahead at 29. 0% versus -19. 5% for Ramaco Resources, Inc. (METC). On earnings-per-share growth, the picture is similar: Hippo Holdings Inc. grew EPS 235. 4% year-over-year, compared to -590. 5% for Ramaco Resources, Inc.. Over a 3-year CAGR, ROOT leads at 69. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RDZN or HIPO or METC or KINS or ROOT?
Kingstone Companies, Inc.
(KINS) is the more profitable company, earning 20. 5% net margin versus -164. 5% for Roadzen, Inc. — meaning it keeps 20. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KINS leads at 25. 6% versus -137. 3% for RDZN. At the gross margin level — before operating expenses — KINS leads at 57. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RDZN or HIPO or METC or KINS or ROOT more undervalued right now?
On forward earnings alone, Kingstone Companies, Inc.
(KINS) trades at 7. 0x forward P/E versus 114. 3x for Hippo Holdings Inc. — 107. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for METC: 41. 0% to $20. 83.
08Which pays a better dividend — RDZN or HIPO or METC or KINS or ROOT?
In this comparison, KINS (0.
6% yield), METC (0. 6% yield) pay a dividend. RDZN, HIPO, ROOT do not pay a meaningful dividend and should not be held primarily for income.
09Is RDZN or HIPO or METC or KINS or ROOT better for a retirement portfolio?
For long-horizon retirement investors, Kingstone Companies, Inc.
(KINS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 28), 0. 6% yield, +101. 9% 10Y return). Root, Inc. (ROOT) carries a higher beta of 2. 30 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KINS: +101. 9%, ROOT: -88. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RDZN and HIPO and METC and KINS and ROOT?
These companies operate in different sectors (RDZN (Technology) and HIPO (Financial Services) and METC (Energy) and KINS (Financial Services) and ROOT (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RDZN is a small-cap quality compounder stock; HIPO is a small-cap high-growth stock; METC is a small-cap quality compounder stock; KINS is a small-cap high-growth stock; ROOT is a small-cap high-growth stock. METC, KINS pay a dividend while RDZN, HIPO, ROOT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.